(Q43515355)

English

Effect of electrocardiographic left ventricular hypertrophy on left ventricular systolic function in systemic hypertension (The LIFE Study). Losartan Intervention For Endpoint

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Effect of electrocardiographic left ventricular hypertrophy on left ventricular systolic function in systemic hypertension (The LIFE Study). Losartan Intervention For Endpoint (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

1 reference

based on heuristic

inferred from title

electrocardiography

1 reference

based on heuristic

inferred from title

left ventricular hypertrophy

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Wachtell K

1

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Rokkedal J

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Bella JN

3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Aalto T

4

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Dahlöf B

5

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Smith G

6

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Roman MJ

7

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Ibsen H

8

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Aurigemma GP

9

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Devereux RB

10

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

language of work or name

0 references

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

87

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

54-60

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Relation of concentric left ventricular hypertrophy and extracardiac target organ damage to supranormal left ventricular performance in established essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901272-8

7 January 2021

Supernormal contractility in primary hypertension without left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901272-8

7 January 2021

Left ventricular wall stress and systolic function in untreated primary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901272-8

7 January 2021

Midwall left ventricular mechanics. An independent predictor of cardiovascular risk in arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901272-8

7 January 2021

Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901272-8

7 January 2021

Electrocardiographic identification of left ventricular hypertrophy: test performance in relation to definition of hypertrophy and presence of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901272-8

7 January 2021

Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population : the LIFE study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901272-8

7 January 2021

Association of carotid atherosclerosis and left ventricular hypertrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901272-8

7 January 2021

Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVE trial)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901272-8

7 January 2021

Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study)∗∗See Appendix for the list of LIFE investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901272-8

7 January 2021

Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901272-8

7 January 2021

Reliability of echocardiographic assessment of left ventricular structure and function

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901272-8

7 January 2021

Reliable estimation of peak left ventricular systolic pressure by M-mode echographic-determined end-diastolic relative wall thickness: identification of severe valvular aortic stenosis in adult patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901272-8

7 January 2021

Relation of arterial structure and function to left ventricular geometric patterns in hypertensive adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901272-8

7 January 2021

Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901272-8

7 January 2021

Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence or absence of asynergy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901272-8

7 January 2021

Evaluation of left ventricular size and function by echocardiography. Results in normal children

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901272-8

7 January 2021

Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901272-8

7 January 2021

Assessment of left ventricular function by meridional and circumferential end-systolic stress/minor-axis shortening relations in dilated cardiomyopathy

2 references

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901272-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901272-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Stress-shortening relations and myocardial blood flow in compensated and failing canine hearts with pressure-overload hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901272-8

7 January 2021

Left ventricular midwall mechanics in systemic arterial hypertension. Myocardial function is depressed in pressure-overload hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901272-8

7 January 2021

Left ventricular stress and compliance in man. With special reference to normalized ventricular function curves

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901272-8

7 January 2021

Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901272-8

7 January 2021

Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901272-8

7 January 2021

The progression from hypertension to congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901272-8

7 January 2021

Midwall fractional shortening is an independent predictor of left ventricular diastolic dysfunction in asymptomatic patients with systemic hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901272-8

7 January 2021

Identifiers

10.1016/S0002-9149(00)01272-8

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43515355&oldid=1990319698"